International Glaucoma Surgical Registry and Elios Vision announce partnership

Article

The open-access tool is the official registry partner of the European Glaucoma Society.

A screen shows a web of file folders, representing data on a digital server. Image credit: ©thodonal – stock.adobe.com

Currently, the IGSR holds data for thousands of procedures across 63 countries. Image credit: ©thodonal – stock.adobe.com

Medical device company Elios Vision, a pioneer in the glaucoma space, announced a partnership with the International Glaucoma Surgical Registry (IGSR). The open-access database is intended to promote information sharing from surgeons worldwide. In a press release, leaders from Elios Vision and the IGSR stated the new collaboration would foster support of, and broader use of, the database.1

“We are delighted to collaborate with and support the objectives of the International Glaucoma Surgical Registry,” said Dr Cameron Hudson, senior vice president OUS of Elios Vision.1 “Capturing long-term, real-world evidence is of high importance especially when adopting and integrating new surgical treatments. We hope the collaboration will encourage other surgeons to utilize the platform for audit and data generation purposes.”

Currently, the IGSR holds data for 7000 procedures across 63 countries. The registry, established over 5 years ago, became the official registry partner of the European Glaucoma Society (EGS) in 2019. Professor Keith Barton, co-founder of the IGSR with Dr Nathan Kerr, also participated in the joint statement.

“We are grateful for the support of Elios Vision in furthering the objectives of the International Glaucoma Surgical Registry and look forward to expanding the capabilities of the Registry through their support,” Barton said.1


Reference

1. Elios Vision Announces Collaboration with the International Glaucoma Surgical Registry. News release. Elios Vision, Inc., July 4, 2023. Accessed July 5, 2023.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.